Back

Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex

Houff, J.; Williams, A.; Allen, O.; Gisabella, B.; Pantazopoulos, H.; Del Arco, A.

2025-12-26 neuroscience
10.64898/2025.12.22.696123 bioRxiv
Show abstract

Clinical trials suggest that a single dose of psilocybin is an effective treatment for substance use disorders (SUDs). Choice impulsivity is a value-based decision-making bias that predicts drug-intake escalation and is commonly associated with SUDs. The dorsomedial prefrontal cortex (dmPFC) regulates choice impulsivity and is enriched with 5-HT2A receptors that mediate effects of psilocybin. We hypothesized that psilocybin has long-term ([≥]48 hours) effects on choice impulsivity in association with dmPFC inhibitory interneurons with perineuronal nets (PNNs). Male Long Evans rats were trained in a delay discounting task (DDT) where rats chose between delayed large rewards (LR) and immediate small rewards (SR). 48 hours after psilocybin or vehicle injections, DDT was assessed, and rats brains processed for microscopy analysis of extracellular matrix (PNNs) together with inhibitory parvalbumin (PV) interneurons and c-fos as a marker of neuronal activity. Psilocybin acutely increased head-twitch responses. Psilocybin decreased LR choices and increased the latency to LR choices 48 hours after administration. These effects were independent of delay and therefore not consistent with changes in impulsivity. Psilocybin also increased the density of PNN+PV+cFos triple-labeled neurons in the dmPFC. These results suggest that psilocybin decreases reward seeking through the increased activation of dmPFC PV interneurons with PNNs.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Psychopharmacology
69 papers in training set
Top 0.1%
32.2%
2
Neuropharmacology
68 papers in training set
Top 0.2%
6.5%
3
European Journal of Neuroscience
189 papers in training set
Top 0.7%
4.2%
4
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
3.9%
5
Behavioural Brain Research
77 papers in training set
Top 0.4%
3.4%
50% of probability mass above
6
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.2%
3.1%
7
Behavioral Neuroscience
25 papers in training set
Top 0.1%
3.0%
8
Addiction Biology
51 papers in training set
Top 0.3%
3.0%
9
Scientific Reports
3612 papers in training set
Top 41%
2.6%
10
eneuro
439 papers in training set
Top 3%
2.6%
11
Frontiers in Behavioral Neuroscience
49 papers in training set
Top 0.4%
2.4%
12
Neuropsychopharmacology
153 papers in training set
Top 1%
2.4%
13
eLife
5828 papers in training set
Top 43%
2.3%
14
Addiction Neuroscience
17 papers in training set
Top 0.1%
2.3%
15
Neurobiology of Learning and Memory
40 papers in training set
Top 0.2%
1.9%
16
The Journal of Neuroscience
1025 papers in training set
Top 7%
1.6%
17
Drug and Alcohol Dependence
41 papers in training set
Top 0.4%
1.5%
18
International Journal of Neuropsychopharmacology
14 papers in training set
Top 0.2%
1.4%
19
Frontiers in Neuroscience
256 papers in training set
Top 5%
1.1%
20
Frontiers in Pharmacology
111 papers in training set
Top 2%
1.1%
21
Translational Psychiatry
260 papers in training set
Top 3%
1.0%
22
Journal of Psychopharmacology
17 papers in training set
Top 0.4%
1.0%
23
Neuroscience
97 papers in training set
Top 2%
1.0%
24
The Journal of Pharmacology and Experimental Therapeutics
18 papers in training set
Top 0.5%
0.8%
25
PLOS ONE
5266 papers in training set
Top 63%
0.8%
26
Journal of Neurophysiology
302 papers in training set
Top 4%
0.8%
27
Alcohol
18 papers in training set
Top 0.3%
0.6%
28
European Neuropsychopharmacology
20 papers in training set
Top 0.7%
0.6%